KR930019216A - 종양 치료제 - Google Patents
종양 치료제 Download PDFInfo
- Publication number
- KR930019216A KR930019216A KR1019920004389A KR920004389A KR930019216A KR 930019216 A KR930019216 A KR 930019216A KR 1019920004389 A KR1019920004389 A KR 1019920004389A KR 920004389 A KR920004389 A KR 920004389A KR 930019216 A KR930019216 A KR 930019216A
- Authority
- KR
- South Korea
- Prior art keywords
- tumor treatment
- isoguanosine
- therapeutic agent
- tumor therapeutic
- active ingredient
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title claims abstract description 5
- MIKUYHXYGGJMLM-UUOKFMHZSA-N Crotonoside Chemical compound C1=NC2=C(N)NC(=O)N=C2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O MIKUYHXYGGJMLM-UUOKFMHZSA-N 0.000 claims abstract description 4
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 claims abstract description 4
- 239000003814 drug Substances 0.000 claims abstract 3
- 229940124597 therapeutic agent Drugs 0.000 claims abstract 3
- 239000004480 active ingredient Substances 0.000 claims abstract 2
- 239000004615 ingredient Substances 0.000 claims 1
- 238000001228 spectrum Methods 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Description
Claims (2)
- 이소구아노신을 유효성분으로 함유하는 종양 치료제.
- 제1항에 있어서, 이소구아노신과 약학적 불활성 성분을 함유하는 종양치료제.※ 참고사항 : 최초출원 내용에 의하여 공개되는 것임.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019920004389A KR100204309B1 (ko) | 1992-03-18 | 1992-03-18 | 종양 치료제 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| KR1019920004389A KR100204309B1 (ko) | 1992-03-18 | 1992-03-18 | 종양 치료제 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| KR930019216A true KR930019216A (ko) | 1993-10-18 |
| KR100204309B1 KR100204309B1 (ko) | 1999-06-15 |
Family
ID=19330509
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1019920004389A KR100204309B1 (ko) | 1992-03-18 | 1992-03-18 | 종양 치료제 |
Country Status (1)
| Country | Link |
|---|---|
| KR (1) | KR100204309B1 (ko) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108659078A (zh) * | 2017-04-01 | 2018-10-16 | 南京泽朗生物科技有限公司 | 一种巴豆苷的提取方法 |
| CN110151776A (zh) * | 2019-04-25 | 2019-08-23 | 四川大学 | 一种双功能核苷水凝胶及其制备方法和用途 |
-
1992
- 1992-03-18 KR KR1019920004389A patent/KR100204309B1/ko not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| KR100204309B1 (ko) | 1999-06-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR940005270A (ko) | 뼈 손실 예방에 유용한 벤조티오펜 | |
| KR900701282A (ko) | 심장 또는 뇌의 허혈성 질환의 치료, 예방제 | |
| GEP20002332B (en) | Cefalosporin Derivatives | |
| ATE15596T1 (de) | Pharmazeutische mittel. | |
| KR890015742A (ko) | 이병치료용 국소 제제 | |
| KR920017655A (ko) | 상처의 치료를 촉진시키기 위한 약학 조성물 | |
| EP0754457A4 (en) | ACTIVE AGAINST ADDICT | |
| RU94044438A (ru) | Применение 2-фенил-3-ароилбензтиофенов для подавления способности к зачатию у женщин | |
| KR930019216A (ko) | 종양 치료제 | |
| DE69314463D1 (de) | Hautregenerierende kosmetische zusammensetzung | |
| DE69532819D1 (de) | Kohlenhydrate derivate und die enthaltende zusammensetzungen | |
| LT96094A (en) | The active ingredient of pharmaceutical composition for treating constipation | |
| CA2136140A1 (en) | Carcinostatic for hormonotherapy containing dienogest as effective component | |
| KR970704442A (ko) | 일시적인 병소 허혈에 의해 유발된 재관류 손상을 치료하기 위한 (S)-아데노실-L-메티오닌(SAMe) 및 그의 생리학상 적합한 염의 용도(Use of (S)-Adenosy-L-Methionine(SAMe) and lts Physiologically Compatible Salts for Treating Reperfusion Damage Triggered by Temporary Focal lschaemia) | |
| KR950007852A (ko) | 우라실을 유효성분으로 함유하는 관절염 치료제 | |
| DE69114922D1 (de) | Polysulfidverbindungen und Lipidperoxidierungsinhibitore, die diese Polysulfidverbindungen als aktive Zutaten enthalten. | |
| ATE169819T1 (de) | (-)-metrifonat enthaltendes arzneimittel | |
| KR940011006A (ko) | 황금추출물을 유효성분으로 하는 치주질환예방 및 치료제 조성물 | |
| KR930019217A (ko) | 종양 치료제 | |
| KR930007451A (ko) | 우리딘을 유효성분으로 함유하는 관절염 치료제 | |
| NO882724L (no) | Smertepreparat. | |
| KR900017599A (ko) | 종양 치료용 약학 조성물 | |
| KR910021244A (ko) | 당뇨병성 괴저 치료제 | |
| KR920019349A (ko) | 불안을 치료하기 위한 r(+)-3-아미노-1-하이드록시-피롤리딘-2-온의 용도 | |
| FR2694292B1 (fr) | Dérivés de benzimidazole-2-thione-, leur préparation et leur application en tant que médicament. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 19920318 |
|
| PG1501 | Laying open of application | ||
| A201 | Request for examination | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 19970317 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 19920318 Comment text: Patent Application |
|
| E701 | Decision to grant or registration of patent right | ||
| PE0701 | Decision of registration |
Patent event code: PE07011S01D Comment text: Decision to Grant Registration Patent event date: 19990222 |
|
| GRNT | Written decision to grant | ||
| PR0701 | Registration of establishment |
Comment text: Registration of Establishment Patent event date: 19990326 Patent event code: PR07011E01D |
|
| PR1002 | Payment of registration fee |
Payment date: 19990327 End annual number: 3 Start annual number: 1 |
|
| PG1601 | Publication of registration | ||
| PR1001 | Payment of annual fee |
Payment date: 20020327 Start annual number: 4 End annual number: 4 |
|
| PR1001 | Payment of annual fee |
Payment date: 20030326 Start annual number: 5 End annual number: 5 |
|
| PR1001 | Payment of annual fee |
Payment date: 20040326 Start annual number: 6 End annual number: 6 |
|
| FPAY | Annual fee payment |
Payment date: 20050325 Year of fee payment: 7 |
|
| PR1001 | Payment of annual fee |
Payment date: 20050325 Start annual number: 7 End annual number: 7 |
|
| LAPS | Lapse due to unpaid annual fee | ||
| PC1903 | Unpaid annual fee |
Termination category: Default of registration fee Termination date: 20070210 |